Radical induction theory of ulcerative colitis

World Journal of Gastroenterology

Volumn 11, Issue 16, 2005, Pages 2371-2384

  Pravda, Jay ^a  

^a NONE   (United States)

Author keywords

Hydrogen peroxide; Oxidative stress; Radical induction; Ulcerative colitis

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BACTERIAL ANTIGEN; CATENIN; CYTOCHROME P450; DNA; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; HYDROXYL RADICAL; OXIDOREDUCTASE; PHOSPHOGLUCONATE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SUPEROXIDE DISMUTASE; TOXIN; TRYPTOPHAN; UVOMORULIN;

ANTIGENICITY; CELL DAMAGE; CELL INFILTRATION; CELL MEMBRANE; CELL METABOLISM; CELL STIMULATION; CELL STRUCTURE; CELLULAR IMMUNITY; CLINICAL FEATURE; COLON MUCOSA; COLORECTAL CANCER; DIARRHEA; DIFFUSION; DISEASE COURSE; DNA DAMAGE; ELECTRON TRANSPORT; ENTERITIS; ENZYME ACTIVITY; ENZYME SYNTHESIS; EPITHELIUM CELL; EXTRACELLULAR SPACE; FECES; HUMAN; IMMUNOGENICITY; INTESTINE ULCER; LEUKOCYTE; MALIGNANT TRANSFORMATION; MENTAL STRESS; NONHUMAN; PATHOGENESIS; PROTEIN SECRETION; REVIEW; SUBMUCOSA; ULCERATIVE COLITIS;

EID: 18744401097     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i16.2371     Document Type: Review

References (147)

1. Hendrickson BA, Gokhale R, Cho JH. Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev 2002; 15: 79-94
2. Farrell JF, Peppercorn M. Ulcerative colitis. Lancet 2002; 359: 331-340
3. Hoffmann JC, Pawlowski NN, Kuhl AA, Hohne W, Zeitz M. Animal models of inflammatory bowel disease: an overview. Pathobiology 2003; 20: 121-130
4. Meyers S, Janowitz HD. The "natural history" of ulcerative colitis: an analysis of the placebo response. J Clin Gastroenterol 1989; 11: 33-37
5. Levine MD, Kirsner JB, Klotz AP. A new concept of the pathogenesis of ulcerative colitis. Science 1951; 114: 52-53
6. Jacobson MA, Kirsner JP. The basement membranes of the epithelium of the colon and rectum in ulcerative colitis and other diseases. Gastroenterology 1956; 30: 279-285
7. Benson K, Bargen J. Fecal impaction. Am J M Sc 1939; 198: 541-545
8. Sheenan J, Brynjolfsson G. Ulcerative colitis following hydrogen peroxide enema. Lab Invest 1960; 9: 150-167
9. Pumphery RE. Hydrogen peroxide proctitis. Am J Surg 1951; 81: 60-62
10. Meyer CT, Brand M, DeLuca VA, Spiro HM. Hydrogen peroxide colitis: a report of three patients. J Clin Gastroenterol 1981; 3: 31-35
11. Bilotta J, Waye JD. Hydrogen peroxide enteritis: the "snow white" sign. Gastrointest Endosc 1989; 35: 428-430
12. Chance B, Sies, H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev 1979; 59: 527-605
13. Enzyme Nomenclature Database [database on the internet]. Geneva Switzerland: Swiss Institute of Bioinformatics, Expert Protein Analysis System [cited 2003 Sept 14]. Search term: H(2) 0(2). Available from URL: http://us.expasy.org/enzyme
14. Thannical VJ, Fanburg BL. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 2000; 279: L1005-L1028
15. Parks DA. Oxygen radicals: mediators of gastrointestinal pathophysiology. Gut 1989; 30: 293-298
16. Eaton JW, Qian M. Molecular basis of cellular iron toxicity. Free Radic Biol Med 2002; 32: 833-840
17. Eberhardt MK. Reactive Oxygen Metabolites: Chemistry and Medical Consequences. CRC Press 2001: the whole book. (Crucial reading for understanding oxygen radicals)
18. Liu SS. Generating, partitioning, targeting and functioning of superoxide in mitochondria. Biosci Rep 1997; 17: 259-272
19. Turrens JF. Superoxide production by the mitochondrial respiratory chain. Biosci Rep 1997; 17: 3-8
20. Cadenas E, Davies KJ. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med 2000; 29: 222-230
21. Boveris A, Chance B. The mitochondrial generation of hydrogen peroxide: general properties and effects of hyperbaric Oxygen. Biochem J 1973; 134: 707-716
22. Lemasters J, Nieminen A. Mitochondria in Pathogenesis. Kluwer Academic/Plenum Publishers 2001: 281-286
23. St-Pierre J, Buckingham JA, Roebuck SJ, Brand MD. Topology of superoxide production from different sites in the mitochondrial electron transport Chain. J Biol Chem 2002; 277: 44784-44790
24. Boveris A, Cadenas E. Mitochondrial production of hydrogen peroxide regulation by nitric oxide and the role of ubisemiquinone. IUBMB Life 2000; 50: 245-250
25. Chen S, Schopfer P. Hydroxyl radical production in physiological reactions. Eur J Biochem 1999; 260: 726-735
26. Fridovich I. Oxygen toxicity: A radical explanation. J Exp Biol 1998; 20: 1203-1209
27. Kehrer JP. The Haber-Weiss reaction and mechanisms of toxicity. Toxicology 2000; 149: 43-50
28. Sheridan AM, Fitzpatrick S, Wang C, Wheeler DC, Lieberthal W. Lipid peroxidation contributes to hydrogen peroxide induced cytotoxicity in renal epithelial cells. Kidney Int 1996; 49: 88-93
29. Esworthy RS, Aranda R, Martin MG, Doroshow JH, Binder SW, Chu FF. Mice with combined disruption of Gpx1 and Gpx2 genes have colitis. Am J Physiol Gastrointest Liver Physiol 2001; 281: G848-855
30. Moskovitz J, Yim MB, Chock PB. Free radicals and disease. Arch Biochem Biophys 2002; 397: 354-359
31. Riedle B, Kerjaschki D. Reactive oxygen species cause direct damage of Englebreth-Holm-Swarm matrix. Am J Pathol 1997; 151: 215-231
32. Stadman ER. Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences. Free Radic Biol Med 1990; 9: 315-325
33. Meyer TN, Schwesinger C, Ye J, Denker BM, Nigam SK. Reassembly of the tight junction after oxidative stress depends on tyrosine kinase activity. J Biol Chem 2001; 276: 22048-22055
34. Schmitz H, Barmeyer C, Gitter AH, Wullstein F, Bentzel CJ, Fromm M, Riecken EO, Schulzke JD. Epithelial barrier and transport function of the colon in ulcerative colitis. New York Academy Sci 2000; 915: 312-326
35. Kalluri R, Cantley LG, Kerjaschki D, Neilson EG. Reactive oxygen species expose cryptic epitopes associated with autoimmune Goodpasture's syndrome. J Biol Chem 2000; 275: 20027-20032
36. Parrish AR, Catania JM, Orozco J, Gandolfi AJ. Chemically induced oxidative stress disrupts e-cadherin/catenin cell adhesion complex. Toxicol Sci 1999; 51: 80-86
37. Rao RK, Baker, RD, Baker SS, Gupta A, Holycross M. Oxidant induced disruption of intestinal epithelial barrier function: role of protein tyrosine phosphorylation. Gastrointest Liver Physiol 1997; 36: G812-G823
38. Grisham MB, Gaginella TS, von Ritter C, Tamai H, Be RM, Granger DN. Effects of neutrophil derived oxidants on intestinal permeability, electrolytic transport and epithelial cell viability. Inflammation 1990; 14: 531-542
39. Lodish H, Berk A, Zirpursky L, Matsuaira P, Baltimore D, Darnell J. Molecular Cell Biology 5th ed. W.H Freeman Co 2004: 201-208
40. Schmehl K, Florian S, Jacobasch G, Salomon A, Korber J. Deficiency of epithelial basement membrane laminin in ulcerative colitis affected human colonic mucosa. Int J Colorectal Dis 2000; 15: 39-48
41. Karayiannakis AJ, Syrigos KN, Efstathiou J, Valizadeh A, Noda M, Playford RJ, Kmiot W, Pignatelli M. Expression of catenins and E-cadherin during epithelial restitution in inflammatory bowel disease. J Pathol 1998; 185: 413-418
42. Jankowski JA, Bedford FK, Boulton RA, Cruickshank N, Hall C, Elder J, Allan R, Forbes A, Kim YS, Wright NA, Sanders DS. Alterations in classical cadherins associated with progression in ulcerative and Crohn's colitis. Laboratory Investigation 1998; 78: 1155-1167
43. Hermiston ML, Gordon JI. In vivo Analysis of cadherin function in the mouse intestinal epithelium. J Cell Biol 1995; 129: 489-506
44. Hermiston ML, Gordon JI. Inflammatory bowel disease and adenomas in mice expressing a dominant negative n-cadherin. Science 1995; 270: 1203-1206
45. Gitter AH, Wullstein F, Fromm M, Schulzke JD. Epithelial barrier defects in ulcerative colitis: characterization and quantification by electrophysiological imaging. Gastroenterology 2001; 121: 1320-1328
46. Kitajima S, Takuma S, Morimoto M. Changes in colonic mucosal permeability in mouse colitis induced with dextran sodium. Exp Anim 1999; 48: 137-143
47. Han D, Williams E, Cadenas E. Mitochondrial respiratory chain-dependent generation of superoxide anion and its release into the intermembrane space. Biochem J 2001; 353: 411-416
48. Boveris A, Oshino N, Chance B. The cellular production of hydrogen peroxide. Biochem J 1972; 128: 617-630
49. Rebrin I, Kamzalov S, Sohal RS. Effects of age and caloric restriction on glutathione redox state in mice. Free Radicals Biol Med 2003; 35: 626-635
50. Geerling BJ, Dagnelie PC, Badart-Smook A, Russel MG, Stockbrugger RW, Brummer RJ. Diet as a risk factor for the development of ulcerative colitis. Am J Gastroenterol 2000; 95: 1008-1013
51. Jarnerot G, Azad Khan AK, Truelove SC. The thyroid in ulcerative colitis and Crohn's disease. Acta Med Scand 1975; 197: 83-87
52. Modebe O. Autoimmune thyroid disease with ulcerative colitis. Postgrad Med J 1986; 62: 475-476
53. Venditti P, Balestrieri M, Di Meo S, De Leo T. Effect of thyroid state on lipid peroxidation, antioxidant defenses, and susceptibility to oxidative stress in rat tissues. J Endocrinol 1997; 155: 151-157
54. Goglia F, Silvestri E, Lanni A. Thyroid hormones and mitochondria. Bioscience Reports 2002; 22: 17-32
55. 2 production by rat heart mitochondria. Sites of production with complex I- and complex II-linked substrates. Horm Metab Res 2003; 35: 55-61
56. Pryor WA, Arbour NC, Upham B, Church DF. The inhibitory effect of extracts of cigarette tar on electron transport of mitochondria and submitochondrial Particles. Free Radicals Biol Med 1992; 12: 365-372
57. Sands B, Compton C. Case records of the Massachusetts General Hospital. Case # 36-1997: A 58-year-old man with recurrent ulcerative colitis, bloody diarrhea, and abdominal distention. New Engl J Med 1997; 337: 1532-1540
58. Odes HS, Fich A, Reif S, Halak A, Lavy A, Keter D, Eliakim R, Paz J, Broide E, Niv Y, Ron Y, Villa Y, Arber N, Gilat T. Effects of current cigarette smoking on clinical course of Crohn's disease and ulcerative colitis. Dig Dis Sci 2001; 46: 1717-1721
59. Abraham N, Selby W, Lazarus R, Solomon M. Is smoking an indirect risk Factor for the development of ulcerative colitis? An age-and sex-matched case-control study. Eur J Gastroenterol Hepatol 2003; 18: 139-146
60. Li C, Jackson RM. Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol Cell Physiol 2002; 282: C227-C241
61. Crohn Burril B. The clinical use of succinyl sulfathiazole (Sulfasuxidine). Gastroenterology 1943; 1: 140-146
62. Kirsner J, Palmer W. Therapeutic problems in ulcerative colitis. Med Clin N Am 1953; 1: 247-259
63. Brown CH. The treatment of acute and chronic ulcerative colitis. Am Pract Dig Treat 1958; 9: 405-411
64. Kirsner J. Ulcerative colitis-a challenge. AMA Arch Int Med 1958; 101: 3-8
65. Tyndel M, Forester W. Chronic ulcerative colitis: recovery after leukotomy. Canadian MAJ 1956; 74: 455-457
66. Levy RW, Wilkins H, Herrmann JD, Lisle AC Jr, Rix A. Experiences with prefrontal lobotomy for intractable ulcerative colitis. JAMA 1956; 60: 1277-1280
67. Levenstein S, Prantera C, Varvo V, Scribano ML, Berto E, Andreoli A, Luzi C. Psychological stress and disease activity in ulcerative colitis: A multidimensional cross-sectional study. Am J Gastroenterol 1994; 89: 1219-1225
68. Theis MK, Boyko EJ. Patient perceptions of causes of inflammatory bowel disease. Am J Gastroenterol 1994; 89: 1920
69. Levenstein S, Prantera C, Varvo V, Scribano ML, Andreoli A, Luzi C, Arca M, Berto E, Milite G, Marcheggiano A. Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled in remission. Am J Gastroenterol 2000; 95: 1213-1220
70. Wood JD, Peck OC, Tefend KS, Stonerook MJ, Caniano DA, Mutabagani KH, Lhotak S, Sharma HM. Evidence that colitis is initiated by environmental stress and sustained by fecal factors in the cotton-top tamarin (Saguinus Oedipus). Dig Dis Sci 2000; 45: 385-393
71. Lechin F, Van der Dijs B, Benaim M. Stress vs. depression. Prog Neuropsychopharm. And Biol Psychiat 1996; 20: 899-950
72. Kurina LM, Goldacre MJ, Yeates D, Gill LE. Depression and anxiety in people with inflammatory bowel disease. J Epidemiol Community Health 2001; 55: 716-720
73. Andrews H, Barczak P, Allen RN. Psychiatric illness in patients with inflammatory bowel disease. Gut 1987; 12: 1600-1604
74. Granger D, Parks D. Role of oxygen radicals in the pathogenesis of intestinal ischemia. The Physiol 1983; 26: 159-164
75. Parks DA, Shah AK, Granger DN. Oxygen radicals: effects on intestinal vascular permeability. Am J Physiol 1984; 247 (2 Pt 1): G167-G170
76. Parks DA, Granger DN. Contributions of ischemia and reperfusion to mucosal lesion formation. Am J Physiol 1986; 250(6 Pt 1): G749-G753
77. Almy TP, Tulin M. Alterations in colonic function in man under stress. Gastroenetrology 1947; 8: 616-626
78. Riaz AA, Wan MX, Schafer T, Dawson P, Menger MD, Jeppsson B, Thorlacius H. Allopurinol and superoxide dismutase protect against leucocyte-endothelium interactions in a novel model of colonic ischaemia-reperfusion. Br J Surg 2002; 12: 1572-1580
79. Laroux FS, Grisham MB. Immunological basis of inflammatory bowel disease. Microcirculation 2001; 8: 283-301
80. Cho JH, Nicolae DL, Ramos R, Fields CT, Rabenau K, Corradino S, Brant SR, Espinosa R, LeBeau M, Hanauer SB, Bodzin J, Bonen DK. Linkage and linkage disequilibrium in chromosome band 1p36 in american chaldeans with inflammatory bowel disease. Human Molecular Genetics 2000; 9: 1425-1432
81. Cho JH, Nicolae DL, Gold LH, Fields CT, LaBuda MC, Rohal PM, Pickles MR, Qin L, Fu Y, Mann JS, Kirschner BS, Jabs EW, Weber J, Hanauer SB, Bayless TM, Brant SR. Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q and 4q:evidence for epistasis between 1p and IBD1. Proc Natl Acad Sci USA 1998; 95: 7502-7507
82. Friedman G, Goldschmidt N, Friedlander Y, Ben-Yehuda A, Selhub J, Babaey S, Mendel M, Kidron M, Bar-On H. A common mutation A1298C in human methylenetetrahydrofolate reductase gene: association with plasma total homocysteine and folate concentrations. J Nutr 1999; 129: 1656-1661
83. Goyette P, Pai A, Milos R, Frosst P, Tran P, Chen Z, Chan M, Rozen R. Gene structure of human and mouse methylenetetrahydrofolate reductase. Mammalian Genome 1998; 9: 652-656
84. Mahmud N, Molloy A, McPartlin J, Corbally R, Whitehead AS, Scott JM, Weir DG. Increased prevalence of methylenetetrahydrofolate reductase C677T variant in patients with inflammatory bowel disease and its clinical implications. Gut 1999; 45: 389-394
85. Nagano M, Nakamura T, Niimi S, Fujino T, Nishimura T, Murayama N, Ishida S, Ozawa S, Saito Y, Sawada J. Substitution of arginine for cysteine 643 of the glucocorticoid receptor reduces its steroid-binding affinity and transcriptional activity. Cancer Lett 2002; 181: 109-114
86. Morgenstern I, Raijmakers MT, Peters WH, Hoensch H, Kirch W. Homocysteine, cysteine, and glutathione in human colonic mucosa. Dig Dis Sci 2003; 48: 2083-2090
87. Upchurch GR Jr, Welch GN, Fabian AJ, Freedman JE, Johnson JL, Keaney JF Jr, Loscalzo J. Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism iInvolving glutathione peroxidase. J Biol Chem 1997; 272: 17012-17017
88. Wilcken DE, Wang XL, Adachi T, Hara H, Duarte N, Green K, Wilcken B. Relationship between homocysteine and superoxide dismutase in homocysteinuria. Aterioscler Thromb Vasc Biol 2000; 20: 1199-1202
89. Chen N, Liu Y, Greiner CD, Holtzman JL. Physiologic concentrations of homocysteine inhibit the human plasma GSH peroxidase that reduces organic hydroperoxides. J Lab Clin Med 2000; 136: 58-65
90. Davidson R. Electrophoretic variants of human 6-phosphogluconate dehydrogenase: population study and family studies and description of a new variant. Ann Hum Genet 1967; 30: 355-361
91. Parr CW. Erythrocyte phosphogluconate dehydrogenase polymorphism. Nature 1966; 210: 487-489
92. Parr CW, Fitch LI. Inherited quantitative variations of human phosphogluconate dehydrogenase. Ann Hum Genet 1967; 30: 339-353
93. Dern RJ, Brewer GJ, Tashian RE, Shows TB. Hereditary variation of erythrocytic 6-phosphogluconate dehydrogenase. J Lab Clin Med 1966; 67: 255-264
94. Nelson MS. Biochemical and genetic characterization of the Lowell variant. New phenotype of 6-phosphogluconate dehydrogenase. Human Genetics 1982; 62: 333-336
95. Caprari P, Caforio MP, Cianciulli P, Maffi D, Pasquino MT, Tarzia A, Amadori S, Salvati AM. 6-Phosphogloconate dehydrogenase deficiency in an italian family. Ann Hematol 2001; 80: 41-44
96. Ciftci M, Beydemir S, Yilmaz H, Bakan E. Effects of some drugs on rat erythrocyte 5-phosphogluconate dehydrogenase. Pol J Pharmacol 2002; 54: 275-280
97. Tomlinson JE, Nakayama R, Holten D. Repression of pentose phosphate pathway dehydrogenase synthesis and mRNA by dietary fat in rats. J Nutr 1998; 118: 408-415
98. Gordillo E, Machado A. Implication of lysine residues in the loss of 6-Phosphogluconate dehydrogenase in aging human erythrocytes. Mech Ageing Dev 1991; 59: 291-297
99. Batist G, Mekhail-Ishak K, Hudson N, DeMuys JM. Interindividual variation in phase II detoxification enzymes in normal colon mucosa. Biochemical Pharmacol 1988; 37: 4241-4243
100. Costa Rosa LF, Curi R, Murphy C, Newsholme P. Effect of adrenaline and phorbol myristate acetate or bacterial lipopolysaccharide on stimulation of pathways of macrophage glucose, glutamine and O2 metabolism. Evidence for cyclic AMP-dependent protein kinase mediated inhibition of glucose-6-phosphate dehydrogenase and activation of NADP+-dependent 'malic' enzyme. Biochem J 1995; 310: 709-714
101. Snawder JE, Lipscomb JC. Interindividual variance of cytochrome P450 forms in human hepatic microsomes. Regul Toxicol Pharmacol 2000; 32: 200-209
102. Bertz J, Granneman GR. Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions. Clin Pharmacokinet 1997; 32: 210-258
103. Jowett SL, Seal CJ, Pearce MS, Phillips E, Gregory W, Barton JR, Welfare MR. Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study. Gut 2004; 53: 1479-1484
104. Hoek JB, Cahill A, Pastorino JG. Alcohol and mitochondria: A dysfunctional relationship. Gastroenterology 2002; 122: 2049-2063
105. Bailey SM, Pietsch EC, Cunningham CC. Ethanol stimulates the production of reactive oxygen species At mitochondrial complexes I and III. Free Radicals Biol Med 1999; 27: 891-900
106. Maher J. Exploring alcohol's effects on liver function. Alcohol Health and Research World. National Institute Alcohol Abuse Alcohol US 1997; 21: 5-12
107. Fernandez-Checa JC, Kaplowitz N, Garcia-Ruiz C, Colell A, Miranda M, Mari M, Ardite E, Morales A. GSH transport in mitochondria: defense against TNF-induced oxidative stress and alcohol-induced defect. Am J Physiol 1997; 273(1 Pt 1): G7-G17
108. Huycke MM, Abrams V, Moore DR. Enterococcus faecalis produces extracellular superoxide and hydrogen peroxide that damages colonic epithelial DNA. Carcinogenesis 2002; 3: 529-536
109. Liochev S, Fridovich I. Superoxide and iron: partners in crime. IUBMB Life 1999; 48: 157-161
110. Owen RW, Spiegelhalder B, Bartsch H. Generation of reactive oxygen species by the fecal matrix. Gut 2000; 46: 225-232
111. Kawai M, Sumimoto S, Kasajima Y, Hamamoto T. A case of ulcerative colitis induced by oral ferrous sulfate. Acta Paediatr Jpn 1992; 34: 476-478
112. Torisu T, Esaki M, Matsumoto T, Nakamura S, Azuma K, Okada M, Tsuji H, Yao T, Iida M. A rare case of ulcerative colitis complicating Wilson's disease: possible association between the two diseases. J Clin Gastroenterol 2002; 35: 43-45
113. Topping DL, Clifton PM. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev 2001; 82: 1031-1064
114. Roediger WE, Nance S. Metabolic induction of experimental ulcerative colitis by inhibition of fatty acid oxidation. Br J Exp Pathol 1986; 67: 773-782
115. Gulati S, Ainol L, Orak J, Singh AK, Singh I. Alterations of peroxisomal function in ischemia-reperfusion injury of rat kidney. Biochim Biophys Acta 1993; 1182: 291-298
116. Bartlett K, Eaton S. Mitochondrial beta-oxidation. Eur J Biochem 2004; 271: 462-469
117. Database of protein families and domains [database on the internet]. Geneva Switzerland: Swiss Institute of Bioinformatics, Expert Protein Analysis System [cited 2003 Dec 27]. Search term: Thiolase. Available from: URL: http://us.expasy.org/prosite
118. Chapman MA, Grahn MF, Boyle MA, Hutton M, Rogers J, Williams NS. Butyrate oxidation is impaired in the colonic mucosa of sufferers of quiescent ulcerative colitis. Gut 1994; 35: 73-76
119. Den Hond E, Hiele M, Evenepoel P, Peeters M, Ghoos Y, Rutgeerts P. In vivo butyrate metabolism and colonic permeability in extensive ulcerative colitis. Gastroenterology 1998; 115: 584-590
120. Harpaz N, Talbot IC. Colorectal cancer in idiopathic inflammatory bowel disease. Seminars Diagnostic Pathol 1996; 13: 339-357
121. Hussain SP, Amstad P, Raja K, Ambs S, Nagashima M, Bennett WP, Shields PG, Ham AJ, Swenberg JA, Marrogi AJ, Harris CC. Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: A cancer prone chronic inflammatory disease. Cancer Res 2000; 60: 3333-3337
122. Olinski R, Gackowski D, Rozalski R, Foksinski M, Bialkowski K. Oxidative DNA damage in cancer patients: a cause or a consequence of the disease development. Mutation Res 2003; 531: 177-190
123. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P. Molecular Biology of the Cell. 4th ed. Taylor Francis Group 2002: 1313-1362
124. Nakamura J, Purvis ER, Swenberg JA. Micromolar concentrations of hydrogen peroxide induce oxidative DNA lesions more efficiently than millimolor concentrations in mammalian cells. Nucleic Acid Res 2003; 31: 1790-1795
125. Rosignoli P, Fabiani R, De Bartolomeo A, Spinozzi F, Agea E, Pelli MA, Morozzi G. Protective activity of butyrate on hydrogen peroxide-induced DNA damage in isolated human colonocytes and HT29 tumour cells. Carcinogenesis 2001; 22: 1675-1680
126. Henle E, Linn S. Formation, Prevention, and repair of DNA damage by iron/hydrogen peroxide. J Biol Chem 1997; 272: 19095-19098
127. Dreher D, Junod AF. Role of oxygen free radicals in cancer development. Eur J Cancer 1996; 32A: 30-38
128. Hu JJ, Dubin N, Kurland D, Ma BL, Roush GC. The effects of hydrogen peroxide on DNA repair activities. Mutation Res 1995; 336: 193-201
129. Munkholm P. Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther 2003; 18(Suppl 2): 1-5
130. Askling J, Dickman PW, Karlen P, Brostrom O, Lapidus A, Lofberg R, Ekbom A. Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population based cohort study. Lancet 2001; 357: 262-266
131. Eaden J. Review article: The data supporting a role for aminosalicylates in the chemoprevention of colorectal cancer in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2003; 18(Suppl 2): 15-21
132. Allgayer H. Review Article: Mechanisms of action of mesalamine in preventing colorectal carcinoma in inflammatory bowel disease. Aliment Pharmacol Ther 2003; 18(Suppl 2): 10-14
133. Eaden J, Abrams K, Ekbom A, Jackson E, Mayberry J. Colorectal cancer prevention in ulcerative colitis: a case-controlled study. Aliment Pharmacol Ther 2000; 14: 145-153
134. Bernstein CN, Blanchard JF, Metge C, Yogendran M. Does the use of 5-aminisalicylates in inflammatory bowel disease prevent the development of colorectal cancer? Am J Gastroenterol 2003; 98: 2784-2788
135. Pearson DC, Jourd'heuil D, Meddings JB. The anti-oxidant properties of 5-aminosalicylic acid. Free Rad Biol Med 1996; 21: 367-373
136. Dull BJ, Salata K, Van Langenhove A, Goldman P. 5-Aminosalicylate: oxidation by activated leukocytes and protection of cultured cells from oxidative damage. Biochemical Pharmacol 1987; 36: 2467-2472
137. Williams J, Hallet M. Effect of sulfasalazine and its active metabolite, 5-aminisalicylic acid, on toxic oxygen metabolite production by neutrophils. Gut 1989; 30: 1581-1587
138. Ahnfelt-Ronne I. The antiinflammatory moiety of sulfasalazine, 5-aminosalicylic acid, is a radical scavenger. Agents Actions 1987; 21: 191-194
139. Yamada T, Volkmer C, Grisham MB. The effects of sulfasalazine metabolites on hemoglobin-catalyzed lipid peroxidation. Free Rad Biol Med 1991; 10: 41-49
140. Roediger W, Babige W. Human colonocyte detoxification. Gut 1997; 41: 731-734
141. Grisham MB, MacDermott RP, Deitch EA. Oxidant defense mechanisms in the human colon. Inflammation 1990; 14: 669-680
142. Bourlioux Pierre. Intestinal flora: role in colonization, resistance and other effects. [monograph on the Internet]. Châtenay-Malabry (France): University of Paris South, Dept of Microbiology [cited 2003 Jan 7] Available from URL: http://h0.web.u-psud.fr/microfun/ch1.html
143. Guyton A. Human Physiology and Mechanisms of Disease. 6th ed. W.B Saunders 1997: 3-4
144. Baron J. Inflammatory bowel disease up to 1932. Mount Sinai J Med 2000; 67: 174-188
145. Grisham MB. Oxidants and free radicals in inflammatory bowel disease. The Lancet 1994; 344: 859-861
146. Kirsner JB. Historical origins of current IBD concepts. World J Gastroenterol 2001; 7: 175-184
147. Cao W, Vrees MD, Kirber MT, Fiocchi C, Pricolo VE. Hydrogen peroxide contributes to motor dysfunction in ulcerative colitis. Am J Physiol Gastrointest Liver Physiol 2004; 286: G833-G843